Determining research priorities for clinician-initiated trials in infectious diseases

David PATERSON, Allen Cheng, A Peleg, Benjamin Howden, David Murdoch, Emma S. McBryde, Ian Woolley, Joshua Davis, Louise Cooley, Monica Slavin, James Robinson, Ronan Murray, Sharon Chen, Tania C Sorrell, Tony Walls, N Bak, Anna Ralph, Sally Havers, Tiffany Brown

    Research output: Contribution to journalComment/debateResearch

    Abstract

    Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).
    Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.
    Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.
    Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.
    Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.
    Original languageEnglish
    Pages (from-to)270-272
    Number of pages3
    JournalMedical Journal of Australia
    Volume198
    Issue number5
    DOIs
    Publication statusPublished - 2013

    Fingerprint

    Communicable Diseases
    Randomized Controlled Trials
    Physicians
    Research
    Infection
    Joints
    Gram-Negative Bacterial Infections
    Outcome Assessment (Health Care)
    Infectious Arthritis
    Diabetic Foot
    Osteomyelitis
    New Zealand
    Staphylococcus aureus
    Therapeutics
    Surveys and Questionnaires

    Cite this

    PATERSON, D., Cheng, A., Peleg, A., Howden, B., Murdoch, D., McBryde, E. S., ... Brown, T. (2013). Determining research priorities for clinician-initiated trials in infectious diseases. Medical Journal of Australia, 198(5), 270-272. https://doi.org/10.5694/mja12.11703
    PATERSON, David ; Cheng, Allen ; Peleg, A ; Howden, Benjamin ; Murdoch, David ; McBryde, Emma S. ; Woolley, Ian ; Davis, Joshua ; Cooley, Louise ; Slavin, Monica ; Robinson, James ; Murray, Ronan ; Chen, Sharon ; Sorrell, Tania C ; Walls, Tony ; Bak, N ; Ralph, Anna ; Havers, Sally ; Brown, Tiffany. / Determining research priorities for clinician-initiated trials in infectious diseases. In: Medical Journal of Australia. 2013 ; Vol. 198, No. 5. pp. 270-272.
    @article{5992313e65d9424b8e560248aec43640,
    title = "Determining research priorities for clinician-initiated trials in infectious diseases",
    abstract = "Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.Results: 122/550 infectious diseases physicians (22{\%}) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.",
    author = "David PATERSON and Allen Cheng and A Peleg and Benjamin Howden and David Murdoch and McBryde, {Emma S.} and Ian Woolley and Joshua Davis and Louise Cooley and Monica Slavin and James Robinson and Ronan Murray and Sharon Chen and Sorrell, {Tania C} and Tony Walls and N Bak and Anna Ralph and Sally Havers and Tiffany Brown",
    year = "2013",
    doi = "10.5694/mja12.11703",
    language = "English",
    volume = "198",
    pages = "270--272",
    journal = "Medical Journal of Australia",
    issn = "0025-729X",
    publisher = "Australasian Medical Publishing Company",
    number = "5",

    }

    PATERSON, D, Cheng, A, Peleg, A, Howden, B, Murdoch, D, McBryde, ES, Woolley, I, Davis, J, Cooley, L, Slavin, M, Robinson, J, Murray, R, Chen, S, Sorrell, TC, Walls, T, Bak, N, Ralph, A, Havers, S & Brown, T 2013, 'Determining research priorities for clinician-initiated trials in infectious diseases', Medical Journal of Australia, vol. 198, no. 5, pp. 270-272. https://doi.org/10.5694/mja12.11703

    Determining research priorities for clinician-initiated trials in infectious diseases. / PATERSON, David; Cheng, Allen; Peleg, A; Howden, Benjamin; Murdoch, David; McBryde, Emma S.; Woolley, Ian; Davis, Joshua; Cooley, Louise; Slavin, Monica; Robinson, James; Murray, Ronan; Chen, Sharon; Sorrell, Tania C; Walls, Tony; Bak, N; Ralph, Anna; Havers, Sally; Brown, Tiffany.

    In: Medical Journal of Australia, Vol. 198, No. 5, 2013, p. 270-272.

    Research output: Contribution to journalComment/debateResearch

    TY - JOUR

    T1 - Determining research priorities for clinician-initiated trials in infectious diseases

    AU - PATERSON, David

    AU - Cheng, Allen

    AU - Peleg, A

    AU - Howden, Benjamin

    AU - Murdoch, David

    AU - McBryde, Emma S.

    AU - Woolley, Ian

    AU - Davis, Joshua

    AU - Cooley, Louise

    AU - Slavin, Monica

    AU - Robinson, James

    AU - Murray, Ronan

    AU - Chen, Sharon

    AU - Sorrell, Tania C

    AU - Walls, Tony

    AU - Bak, N

    AU - Ralph, Anna

    AU - Havers, Sally

    AU - Brown, Tiffany

    PY - 2013

    Y1 - 2013

    N2 - Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.

    AB - Objectives: To determine research priorities of infectious diseases physicians for clinician-initiated randomised controlled trials (RCTs).Design, setting and participants: Online survey of infectious diseases physicians in Australia and New Zealand.Main outcome measures: Research priorities for, and perceived barriers to, clinician-initiated RCTs.Results: 122/550 infectious diseases physicians (22%) responded to the survey. The five highest ranked proposals for clinician-initiated RCTs were in the areas of prosthetic joint infections, septic arthritis and osteomyelitis of native joints, Staphylococcus aureus bloodstream infections, diabetic foot infections and the treatment of serious multiresistant, gram-negative bacterial infections. Lack of funding was the most important perceived barrier to participation in clinician-initiated RCTs.Conclusions: The research focus of infectious diseases physicians — optimal treatment of commonly encountered serious infections — highlights a lack of well conducted RCTs in this area.

    U2 - 10.5694/mja12.11703

    DO - 10.5694/mja12.11703

    M3 - Comment/debate

    VL - 198

    SP - 270

    EP - 272

    JO - Medical Journal of Australia

    JF - Medical Journal of Australia

    SN - 0025-729X

    IS - 5

    ER -